These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22607765)

  • 1. The next generation of biologic agents: therapeutic role in relation to existing therapies in metastatic breast cancer.
    Conte P; Guarneri V
    Clin Breast Cancer; 2012 Jun; 12(3):157-66. PubMed ID: 22607765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lapatinib and ixabepilone for the treatment of metastatic breast cancer.
    Halterman PA
    Pharmacotherapy; 2008 Oct; 28(10):1255-66. PubMed ID: 18823221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of the contemporary cytotoxic and biologic combinations available for the treatment of metastatic breast cancer.
    Tkaczuk KH
    Clin Ther; 2009; 31 Pt 2():2273-89. PubMed ID: 20110041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current and emerging targeted therapies for metastatic breast cancer.
    Perez EA; Spano JP
    Cancer; 2012 Jun; 118(12):3014-25. PubMed ID: 22006669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond cytotoxic chemotherapy for the first-line treatment of HER2-negative, hormone-insensitive metastatic breast cancer: current status and future opportunities.
    Conlin AK; Seidman AD
    Clin Breast Cancer; 2008 Jun; 8(3):215-23. PubMed ID: 18650151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Other options in the treatment of advanced breast cancer.
    Cobleigh MA
    Semin Oncol; 2011 Jun; 38 Suppl 2():S11-6. PubMed ID: 21600380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New cytotoxic agents and molecular-targeted therapies in the treatment of metastatic breast cancer.
    Awada A
    Forum (Genova); 2002; 12(1):4-15. PubMed ID: 12634907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Approved agents for metastatic breast cancer.
    Fornier MN
    Semin Oncol; 2011 Jun; 38 Suppl 2():S3-10. PubMed ID: 21600382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anthracycline- and/or taxane-resistant breast cancer: results of a literature review to determine the clinical challenges and current treatment trends.
    Moreno-Aspitia A; Perez EA
    Clin Ther; 2009 Aug; 31(8):1619-40. PubMed ID: 19808124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platinum compounds in the treatment of advanced breast cancer.
    Martín M
    Clin Breast Cancer; 2001 Oct; 2(3):190-208; discussion 209. PubMed ID: 11899413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging targeted therapies for breast cancer.
    Alvarez RH; Valero V; Hortobagyi GN
    J Clin Oncol; 2010 Jul; 28(20):3366-79. PubMed ID: 20530283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted therapies for non-small cell lung cancer.
    Dempke WC; Suto T; Reck M
    Lung Cancer; 2010 Mar; 67(3):257-74. PubMed ID: 19914732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging drugs in metastatic breast cancer: an update.
    Arslan C; Altundag K; Dizdar O
    Expert Opin Emerg Drugs; 2011 Dec; 16(4):647-67. PubMed ID: 22122529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastatic breast cancer: understanding current management options.
    McGinn K; Moore J
    Oncol Nurs Forum; 2001 Apr; 28(3):507-12; quiz 513-4. PubMed ID: 11338758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An overview of HER-targeted therapy with lapatinib in breast cancer.
    McArthur H
    Adv Ther; 2009 Mar; 26(3):263-71. PubMed ID: 19365626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of chemotherapy and targeted agents in patients with metastatic breast cancer.
    Johnston SR
    Eur J Cancer; 2011 Sep; 47 Suppl 3():S38-47. PubMed ID: 21944023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current trends in pharmacotherapy of breast cancer].
    Boér K
    Orv Hetil; 2002 Apr; 143(14):725-30. PubMed ID: 11975393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination chemotherapy for metastatic breast cancer.
    Nabholtz JM; Reese DM; Lindsay MA; Riva A
    Expert Rev Anticancer Ther; 2002 Apr; 2(2):169-80. PubMed ID: 12113239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in adjuvant therapy for breast cancer.
    Slamon DJ; Romond EH; Perez EA;
    Clin Adv Hematol Oncol; 2006 Mar; 4(3 Suppl 7):suppl 1, 4-9; discussion suppl 10; quiz 2 p following suppl 10. PubMed ID: 16736568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of metastatic breast cancer: monotherapy options for patients resistant to anthracyclines and taxanes.
    Rivera E
    Am J Clin Oncol; 2010 Apr; 33(2):176-85. PubMed ID: 19675449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.